spice turmeric

There’s more evidence that cancer researchers might do well to spice up their mesothelioma clinical trials. A team of researchers at Keio University in Tokyo report that curcumin, the primary component in the spice turmeric, can effectively reduce the viability of human mesothelioma cells in the laboratory. This, despite the fact that mesothelioma is notoriously resistant to many types of conventional cancer therapies. “Curcumin, which has a long history as a dietary spice, is known to suppress the growth of multiple cancer lines, but the effects on mesothelioma cells are not well-defined,” observed principal investigator Y. Yamauchi in Phytotherapy Research. Mesothelioma is an aggressive cancer of internal membranes, triggered by asbestos exposure. Citing mesothelioma’s well-known treatment resistance, Yamauchi says alternative…